Epidemiology
More common in women in men
Present in examination in up to 9% of population
Majority are painless, but pain and discomfort can occur in acute presentation
Large goitres can produce dysphagia and breathing difficulty, and
superior vena cava obstruction
Can be physiological or pathological
Diffuse
Nodular
Solitary:
Tumours
Adenoma
Misc
Simple: physiological
Multinodular goitre
Carcinoma
Tuberculosis
Fibrotic (Reidels
thyroiditis, form of
autoimmune)
Lymphoma
Iodine deficiency
(endemic goitre)
Dyshormonogenesis
Goitrogens (eg
sulfonylureas)
Cysts
Sarcoidosis
Solitary toxic nodules are uncommon and may be associated with T3 toxicosis,
or are toxic adenomas (follicular in origin).
Tumours
Thyroid carcinoma
Rarely the site of a metastatic deposit or the site of origin of lymphoma
Investigation
TEST
TFTs
Thyroid antibodies
Ultrasound
EXPLANATION
TSH and Free T4 or T3
To exclude autoimmune aetiology
High-resolution can delineate nodules, esp
clinically undetectable multinodular goitre
Differentiates between cystic and solid
FNA usually also performed (for possibly
malignant cystic tumours and thyroid
tumours)
Tracheal compression, large retrosternal
extensions
Fine-needle aspiration
Suppressed
(<0.05 mU/L)
Increased (>10
mU/L)
Low-normal or
subnormal
Suppressed (<0.05
mU/L)
Slightly
increased (5-10
mU/L)
Free T4 (10-18.7
pmol/L)
Increased
Free T3 (3.5-6.5
pmol/L)
Increased
Low/low-normal
Normal/low
Low/low-normal
Normal/low
Normal
Increased
Normal
Normal
Detailed management
Many goitres are small, cause no symptoms and can be observed (includes patient
self-monitoring). When it is physiological it is likely to spontaneously resolve.
When thyroid function is abnormal, the patient should be treated so that they are
euthyroid.
Surgical intervention is indicated when:
Malignancy is suspected
o Rapid growth
o Pain
o Cervical lymphadenopathy
o Change in voice (recurrent laryngeal nerve compression)
o Previous radiation
o Positive or suspicious FNA
Pressure symptoms on the trachea or more rarely, the oesophagus are detected
(retrosternal extension)
Cosmetic reasonspatients may be anxious over appearance
Radioactive iodine is an option in euthyroid goitre, particularly when surgery is
unattractive.
Toxic nodules are managed with antithyroid drugs, but surgery or radioiodine is often
required.
Thyroid carcinoma
Epidemiology
Not common, and more common in females
Mortality from it not that high
In 90% of cases they present as thyroid nodules
Occasionally with cervical lymphadenopathy (5%), or with lung, cerebral,
hepatic or bone metastases
Follicular
(Hurthle cells)
Frequen
cy
70%-most
common
20%
Behavio
ur
Occurs in
young
people
More
common
in
females
Spread
Prognosis Treatment
Local lymph
nodes,
sometimes
lung/bone
metastasis via
blood
Good,
especially
in young
Metastasises
to lung/bone
via blood
Good if
resectable,
has
propensity
to take up
Total thyroidectomy
+/- node excision +/radioiodine; thyroxine
to suppress TSH and
growth
Monitor with
thyroglobulin
antibodiesshould
have no thyroglobulin
left
Same as above
131Iodine and
so maybe
good
prognosis
Very poor
Anaplastic
(dedifferentiation
)
Medullary cell
(neuroendocri
ne tumour)
<5%
Aggressi
ve, in
elderly
Locally
invasive
5%
Often
familial
(Multiple
Endocrin
e
Neoplasi
a 2)
Local
invasion;
lymphatic
spread and
eventually via
blood to the
liver
Poor, but
indolent
course
(causing
little or no
pain)
Lymphoma;
non-Hodgkin,
non B-cell
2%
Variable;
may
present
with
stridor or
dysphagi
a
Lymphatic
spread
Sometime
s
responsive
to
radiothera
py
Excision or
radiotherapy if it is
resectable
Do
phaeochromocytoma
screen; screen
asymptomatic
relatives,
thyroidectomy and
node clearance. Does
not respond to radioiodine.
Stage lymphoma pre
treatment;
chemoradiotherapy. If
MALT origin, good
prognosis
Pathophysiology
Uncertain, but papillary carcinoma can be familial (eg inherited MAPK defects) and
those related to previous head and neck irradiation or ingestion of radioactive iodine.
Hormonally, these tumours are minimally active but secrete thyroglobulin, which
can act as a tumour marker. Also used after adjuvant radiotherapy for any
cancer activity.
Medullary cell carcinoma: calcitonin levels as tumour marker.
Medullary carcinoma: a neuroendocrine tumour, often associated with multiple
endocrine neoplasia type 2 (RET proto-oncogene mutation, familial cancer syndrome,
often with other mucosal neuromas/parathyroid hyperplasia).
In detail
Papillary
Young, good prognosis
Tends to spread to
o Pretracheal and prelaryngeal nodes, usually a small occult tumour
o Deep cervical chain following superior and middle thyroid veins
o Nodes around RLN and anterior mediastinum following inferior thyroid
veins
o Does not metastasise beyond head and neck
Treatment
General
Ablation radio-iodine
Thyroxine after surgeryreplace and to suppress TSH
Papillary and follicular carcinoma:
Surgical, normally total or near-total thyroidectomy for local disease
Regional or more extensive neck dissection is needed where there is local nodal
spread or involvement of local structures
Radioactive iodine is recommended to ablate residual thyroid tissue postoperatively for most patients with differentiated thyroid cancer
If it recurs, local thyroid invasion and lymph node involvement is common
Lungs and bone are most common sites of distant metastasis
Suppressive doses of levothyroxine to minimise TSH levels below the normal
range, and minimises risk of recurrence.
Serum thyroglobulin levels are used to monitor patient progress
Prognosis is extremely good when they are confined to the thyroid gland
o Higher riskage >40
o Larger primary tumour size (>4cm)
o Macroscopic invasion of capsule and surrounding tissues